The Global Biosimilar Market is expected to be valued at USD 159,020 million by 2033 from USD 15,600 million in 2023, at a CAGR of 23.5% during the forecast period. Market growth is majorly pushed by the rising incidence of chronic diseases and increasing demand of Bio-Similar for their cost-effectiveness.
Get A Report Copy of this Market: https://wemarketresearch.com/r....eports/biosimilars-m